Novozymes optimistic about Bioenergy despite less US production
In the fourth quarter, Novozymes’ bioethanol production declined by 5% in the US. Nevertheless, the Danish enzyme producer managed to secure organic growth of 22% in the Bioenergy division in Q4 and noted 25% growth for the full year.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Novozymes surges yet again on Bioenergy
For subscribers